Indefinite Delivery Contract SPE2D018D0006

Award Date 3/7/18
Last Date to Order 3/6/28
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DU25D1032 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at $4,999,999, runs through December 31, 2036 and serves as the primary vehicle for the DLA Troop Support Medical division to procure essential medical commodities such as specialty...
This is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued up to $999,999,999, runs through December 2025 and aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses the delivery of critical medical commodities including specialty...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA), valued at $4,999,999 and valid through December 2036. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications,...
The Defense Logistics Agency awarded a single-award indefinite-delivery/indefinite-quantity contract to DMS Pharmaceutical Group Inc. to supply pharmaceutical products and services in support of Department of Defense programs. The contract has a potential value of $499,999,999 and period of performance through December 2025. The task orders issued against the contract by DLA between June and July 2022 procured a range of pharmaceutical products for delivery to locations in Park Ridge,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, with an estimated total value of $30.3 billion. The contract covers a comprehensive range of pharmaceutical products and medical supplies, including specialty...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $4,999,999.99, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes a variety of essential medical commodities such as specialty medications, brand-name and generic drugs, vaccines,...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at up to $9,999,999.00, runs through December 31, 2025 and serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
This indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and runs through November 2026. The contract encompasses a broad array of medical commodities including specialty...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 single award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This IDC, which runs through December 2036, serves as a primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) valued up to $999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November 2026, encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines,...
  • SPE2D018D0006
    Indefinite Delivery Contract
  • 242
    Federal Contract Awards

The Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, awarded an Indefinite Delivery Contract (IDC) with ID SPE2D018D0006 to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at up to $6,623,741.40, is for the delivery of critical pharmaceutical products, primarily the drug Ryanodex 250mg vials, which are used to treat and prevent malignant hyperthermia in high-risk patients.

Through a series of firm fixed-price delivery orders issued under this IDC, Eagle Pharmaceuticals will supply the specified pharmaceutical products to support medical readiness initiatives for the Department of Defense. The contract does not utilize any set-aside designations, indicating that Eagle Pharmaceuticals competed for and was awarded the contract through open market competition. Additionally, Eagle Pharmaceuticals holds a significant Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) Veterans Health Administration, enabling the VA and DLA to efficiently procure a wide range of pharmaceutical products from the company to support federal healthcare infrastructure.

Generated 7/22/25, 9:47 AM